pH-responsive antibodies for therapeutic applications

Abstract Therapeutic antibodies are instrumental in improving the treatment outcome for certain disease conditions. However, to enhance their efficacy and specificity, many efforts are continuously made. One of the approaches that are increasingly explored in this field are pH-responsive antibodies...

Full description

Bibliographic Details
Main Authors: Tomasz Klaus, Sameer Deshmukh
Format: Article
Language:English
Published: BMC 2021-01-01
Series:Journal of Biomedical Science
Subjects:
Online Access:https://doi.org/10.1186/s12929-021-00709-7
id doaj-a8f2bf41eccb4cbebf4e6ee2b081846d
record_format Article
spelling doaj-a8f2bf41eccb4cbebf4e6ee2b081846d2021-01-24T12:22:24ZengBMCJournal of Biomedical Science1423-01272021-01-0128111410.1186/s12929-021-00709-7pH-responsive antibodies for therapeutic applicationsTomasz Klaus0Sameer Deshmukh1Research and Development Department, Pure Biologics, Inc.Research and Development Department, Pure Biologics, Inc.Abstract Therapeutic antibodies are instrumental in improving the treatment outcome for certain disease conditions. However, to enhance their efficacy and specificity, many efforts are continuously made. One of the approaches that are increasingly explored in this field are pH-responsive antibodies capable of binding target antigens in a pH-dependent manner. We reviewed suitability and examples of these antibodies that are functionally modulated by the tumor microenvironment. Provided in this review is an update about antigens targeted by pH-responsive, sweeping, and recycling antibodies. Applicability of the pH-responsive antibodies in the engineering of chimeric antigen receptor T-cells (CAR-T) and in improving drug delivery to the brain by the enhanced crossing of the blood–brain barrier is also discussed. The pH-responsive antibodies possess strong treatment potential. They emerge as next-generation programmable engineered biologic drugs that are active only within the targeted biological space. Thus, they are valuable in targeting acidified tumor microenvironment because of improved spatial persistence and reduced on-target off-tumor toxicities. We predict that the programmable pH-dependent antibodies become powerful tools in therapies of cancer.https://doi.org/10.1186/s12929-021-00709-7Antibody generationpH-responsive antibodiesRecycling antibodiesSweeping antibodiesTumor microenvironmentCAR-T cells
collection DOAJ
language English
format Article
sources DOAJ
author Tomasz Klaus
Sameer Deshmukh
spellingShingle Tomasz Klaus
Sameer Deshmukh
pH-responsive antibodies for therapeutic applications
Journal of Biomedical Science
Antibody generation
pH-responsive antibodies
Recycling antibodies
Sweeping antibodies
Tumor microenvironment
CAR-T cells
author_facet Tomasz Klaus
Sameer Deshmukh
author_sort Tomasz Klaus
title pH-responsive antibodies for therapeutic applications
title_short pH-responsive antibodies for therapeutic applications
title_full pH-responsive antibodies for therapeutic applications
title_fullStr pH-responsive antibodies for therapeutic applications
title_full_unstemmed pH-responsive antibodies for therapeutic applications
title_sort ph-responsive antibodies for therapeutic applications
publisher BMC
series Journal of Biomedical Science
issn 1423-0127
publishDate 2021-01-01
description Abstract Therapeutic antibodies are instrumental in improving the treatment outcome for certain disease conditions. However, to enhance their efficacy and specificity, many efforts are continuously made. One of the approaches that are increasingly explored in this field are pH-responsive antibodies capable of binding target antigens in a pH-dependent manner. We reviewed suitability and examples of these antibodies that are functionally modulated by the tumor microenvironment. Provided in this review is an update about antigens targeted by pH-responsive, sweeping, and recycling antibodies. Applicability of the pH-responsive antibodies in the engineering of chimeric antigen receptor T-cells (CAR-T) and in improving drug delivery to the brain by the enhanced crossing of the blood–brain barrier is also discussed. The pH-responsive antibodies possess strong treatment potential. They emerge as next-generation programmable engineered biologic drugs that are active only within the targeted biological space. Thus, they are valuable in targeting acidified tumor microenvironment because of improved spatial persistence and reduced on-target off-tumor toxicities. We predict that the programmable pH-dependent antibodies become powerful tools in therapies of cancer.
topic Antibody generation
pH-responsive antibodies
Recycling antibodies
Sweeping antibodies
Tumor microenvironment
CAR-T cells
url https://doi.org/10.1186/s12929-021-00709-7
work_keys_str_mv AT tomaszklaus phresponsiveantibodiesfortherapeuticapplications
AT sameerdeshmukh phresponsiveantibodiesfortherapeuticapplications
_version_ 1724325922544287744